This page includes the latest FDA filings for Stemline Therapeutics Inc. Currently, you will find the latest 100 filings for Premarket Notifications, Premarket Applications, De Novo Applications, and GUDID registrations.
USA | NASDAQ | STML | DUNS 139606136 |
Device Company | Device | Date |
---|---|---|
Stemline Therapeutics, Inc. | Prescription Medication | 2024-08-05 |
Stemline Therapeutics, Inc. | Prescription Medication | 2023-11-23 |
Stemline Therapeutics, Inc., Alcami Carolinas Corporation | Prescription Medication | 2023-08-04 |
Stemline Therapeutics, Inc. | Prescription Medication | 2023-02-10 |
Stemline Therapeutics, Inc. | Prescription Medication | 2023-02-07 |
STEMLINE THERAPEUTICS INC | 2023-02-03 22:03:41 | |
Stemline Therapeutics, Inc., Alcami Carolinas Corporation | Prescription Medication | 2022-11-15 |
Stemline Therapeutics, Inc., Alcami Carolinas Corporation | Prescription Medication | 2022-11-10 |
Stemline Therapeutics, Inc., Alcami Carolinas Corporation | Prescription Medication | 2022-02-01 |
Stemline Therapeutics, Inc., Alcami Carolinas Corporation | Prescription Medication | 2020-06-10 |
Stemline Therapeutics, Inc., Alcami Carolinas Corporation | Prescription Medication | 2019-02-26 |
Stemline Therapeutics, Inc. | Elzonris | 2019-01-18 |
STEMLINE THERAPEUTICS INC | 0000-00-00 00:00:00 |
NCAGE Code | 4CJM1 | STEMLINE THERAPEUTICS, INC. |
CAGE Code | 4CJM1 | STEMLINE THERAPEUTICS, INC. |
S.A.M. Registration | 4CJM1 [139606136] | STEMLINE THERAPEUTICS, INC. |
SEC | 0001264587 | STEMLINE THERAPEUTICS INC of DELAWARE |